These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 17300814

  • 1. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
    Takamura M, Matsuda Y, Yamagiwa S, Tamura Y, Honda Y, Suzuki K, Ichida T, Aoyagi Y.
    Life Sci; 2007 Mar 13; 80(14):1335-44. PubMed ID: 17300814
    [Abstract] [Full Text] [Related]

  • 2. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T, Hirono S, Moriuchi A, Hasuike S, Nagata K, Hori T, Ido A, Hayashi K, Tsubouchi H.
    Hepatology; 2001 Jun 13; 33(6):1441-50. PubMed ID: 11391533
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM.
    Eur J Pharmacol; 2014 Sep 05; 738():66-73. PubMed ID: 24877692
    [Abstract] [Full Text] [Related]

  • 4. Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure.
    Lian LH, Wu YL, Wan Y, Li X, Xie WX, Nan JX.
    Chem Biol Interact; 2010 Oct 06; 188(1):127-33. PubMed ID: 20558151
    [Abstract] [Full Text] [Related]

  • 5. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q, Jiang S, Wu YL, Bai T, Yang Y, Jin X, Lian LH, Nan JX.
    Phytomedicine; 2014 Jan 15; 21(2):141-7. PubMed ID: 24011530
    [Abstract] [Full Text] [Related]

  • 6. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
    Wu YL, Lian LH, Wan Y, Nan JX.
    Chem Biol Interact; 2010 Dec 05; 188(3):526-34. PubMed ID: 20850421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z, Avlas O, Pappo O, Zilbermints V, Cheporko Y, Bachmetov L, Zemel R, Shainberg A, Sharon E, Grief F, Hochhauser E.
    Cell Physiol Biochem; 2012 Dec 05; 29(1-2):41-50. PubMed ID: 22415073
    [Abstract] [Full Text] [Related]

  • 9. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
    Banskota AH, Nguyen NT, Tezuka Y, Le Tran Q, Nobukawa T, Kurashige Y, Sasahara M, Kadota S.
    Life Sci; 2004 Apr 16; 74(22):2781-92. PubMed ID: 15043992
    [Abstract] [Full Text] [Related]

  • 10. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW, Kim DW, Choi JS, Kim YS, Lee SM.
    Food Chem Toxicol; 2013 Jul 16; 57():132-9. PubMed ID: 23535186
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal administration of fetuin-A attenuates D-galactosamine/lipopolysaccharide-induced liver failure in mouse.
    Zhang P, Shen H, Huang J, Wang H, Zhang B, Zhou R, Zhong B, Fan X.
    Dig Dis Sci; 2014 Aug 16; 59(8):1789-97. PubMed ID: 24604240
    [Abstract] [Full Text] [Related]

  • 12. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
    Kim SJ, Kim JK, Lee DU, Kwak JH, Lee SM.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):188-93. PubMed ID: 20303938
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Betulinic acid prevention of d-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms.
    Zheng ZW, Song SZ, Wu YL, Lian LH, Wan Y, Nan JX.
    J Pharm Pharmacol; 2011 Apr 10; 63(4):572-8. PubMed ID: 21401610
    [Abstract] [Full Text] [Related]

  • 16. Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury.
    Xiong Q, Hase K, Tezuka Y, Namba T, Kadota S.
    Life Sci; 1999 Apr 10; 65(4):421-30. PubMed ID: 10421428
    [Abstract] [Full Text] [Related]

  • 17. Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
    Cho HI, Park JH, Choi HS, Kwak JH, Lee DU, Lee SK, Lee SM.
    J Nat Prod; 2014 Nov 26; 77(11):2497-503. PubMed ID: 25382719
    [Abstract] [Full Text] [Related]

  • 18. Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway.
    Chang A, Chen Y, Shen W, Gao R, Zhou W, Yang S, Liu Y, Luo Y, Chuang TH, Sun P, Liu C, Xiang R.
    J Infect Dis; 2015 Nov 01; 212(9):1509-20. PubMed ID: 26459629
    [Abstract] [Full Text] [Related]

  • 19. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X, Su C, Fu J, Zhang P, Jiang X, Xu D, Hu L, Song E, Song Y.
    Int Immunopharmacol; 2014 Oct 01; 22(2):293-302. PubMed ID: 25046589
    [Abstract] [Full Text] [Related]

  • 20. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Lee WC, Kim JK, Kang JW, Oh WY, Jung JY, Kim YS, Jung HA, Choi JS, Lee SM.
    Food Chem Toxicol; 2010 Jan 01; 48(1):222-8. PubMed ID: 19818826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.